Based on these findings, we attempt to quantitatively assess the association between the Arg72Pro (rs1042522) polymorphisms of the TP53 gene and T309G of the MDM2 gene with the susceptibility to developing bladder cancer. Here, MDM2 is linked to urinary bladder carcinoma.